CoChat

OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations

Pan, Zoucheng, Zhang, Ruyang, Shen, Sipeng, Lin, Yunzhi, Zhang, Longyao, Wang, Xiang, Ye, Qian, Wang, Xuan, Chen, Jiajin, Zhao, Yang, Christiani, David C., Li, Yi, Chen, Feng, Wei, Yongyue · 2023 · eBioMedicine
Cited by 43

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2023.104443

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 38

  1. Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209
  2. Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 · DOI · Paper page
  3. Moyer, 2014, Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 160, 330, 10.7326/M13-2771 · DOI · Paper page
  4. Field, 2016, The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer, Health Technol Assess, 20, 1, 10.3310/hta20400 · DOI · Paper page
  5. Oudkerk, 2017, European position statement on lung cancer screening, Lancet Oncol, 18, e754, 10.1016/S1470-2045(17)30861-6 · DOI · Paper page
  6. Oudkerk, 2021, Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives, Nat Rev Clin Oncol, 18, 135, 10.1038/s41571-020-00432-6 · DOI · Paper page
  7. Tammemägi, 2021, USPSTF2013 vs. PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study, Lancet Oncol, 23, 138, 10.1016/S1470-2045(21)00590-8 · DOI · Paper page
  8. Ten Haaf, 2020, A comparative modeling analysis of risk-based lung cancer screening strategies, J Natl Cancer Inst, 112, 466, 10.1093/jnci/djz164 · DOI
  9. Toumazis, 2020, Risk-based lung cancer screening: a systematic review, Lung Cancer, 147, 154, 10.1016/j.lungcan.2020.07.007 · DOI · Paper page
  10. Tammemägi, 2013, Selection criteria for lung-cancer screening, N Engl J Med, 368, 728, 10.1056/NEJMoa1211776 · DOI · Paper page
  11. Cassidy, 2008, The LLP risk model: an individual risk prediction model for lung cancer, Br J Cancer, 98, 270, 10.1038/sj.bjc.6604158 · DOI · Paper page
  12. Field, 2021, Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation, Thorax, 76, 161, 10.1136/thoraxjnl-2020-215158 · DOI
  13. Tammemägi, 2014, Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts, PLoS Med, 11, 10.1371/journal.pmed.1001764 · DOI · Paper page
  14. Mazzone, 2021, Screening for lung cancer: CHEST guideline and expert panel report, Chest, 160, e427, 10.1016/j.chest.2021.06.063 · DOI · Paper page
  15. Hong, 2022, A comparison of XGBoost, random forest, and nomograph for the prediction of disease severity in patients with COVID-19 pneumonia: implications of cytokine and immune cell profile, Front Cell Infect Microbiol, 12, 10.3389/fcimb.2022.819267 · DOI
  16. Lyu, 2020, The development and validation of risk prediction model for lung cancer: a systematic review, Zhonghua Yu Fang Yi Xue Za Zhi, 54, 430
  17. Horsfall, 2020, Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank, Thorax, 75, 955, 10.1136/thoraxjnl-2020-214756 · DOI
  18. Hung, 2021, Assessing lung cancer absolute risk trajectory based on a polygenic risk model, Cancer Res, 81, 1607, 10.1158/0008-5472.CAN-20-1237 · DOI
  19. Zhang, 2022, A large-scale genome-wide gene-gene interaction study of lung cancer susceptibility in Europeans with a trans-ethnic validation in asians, J Thorac Oncol, 17, 974, 10.1016/j.jtho.2022.04.011 · DOI
  20. Friedman, 2002, Stochastic gradient boosting, Comput Stat Data Anal, 38, 367, 10.1016/S0167-9473(01)00065-2 · DOI · Paper page
  21. Verwaeren, 2015, A search grid for parameter optimization as a byproduct of model sensitivity analysis, Appl Math Comput, 261, 8
  22. Katki, 2016, Development and validation of risk models to select ever-smokers for CT lung cancer screening, JAMA, 315, 2300, 10.1001/jama.2016.6255 · DOI · Paper page
  23. Rutter, 2003, Estimating the accuracy of psychological scales using longitudinal data, Biostatistics, 4, 97, 10.1093/biostatistics/4.1.97 · DOI
  24. Heagerty, 2000, Time-dependent ROC curves for censored survival data and a diagnostic marker, Biometrics, 56, 337, 10.1111/j.0006-341X.2000.00337.x · DOI · Paper page
  25. Abe, 2022, A prehospital triage system to detect traumatic intracranial hemorrhage using machine learning algorithms, JAMA Netw Open, 5, 10.1001/jamanetworkopen.2022.16393 · DOI
  26. He, 2009, Learning from imbalanced data, IEEE Trans Knowl Data Eng, 21, 1263, 10.1109/TKDE.2008.239 · DOI · Paper page
  27. Li, 2020, Deep learning on high-throughput transcriptomics to predict drug-induced liver injury, Front Bioeng Biotechnol, 8, 10.3389/fbioe.2020.562677 · DOI
  28. Wilcox, 2022, Chapter 5 - comparing two groups, 153
  29. Bandos, 2005, A permutation test sensitive to differences in areas for comparing ROC curves from a paired design, Stat Med, 24, 2873, 10.1002/sim.2149 · DOI · Paper page
  30. Robbins, 2021, Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom, Br J Cancer, 124, 2026, 10.1038/s41416-021-01278-0 · DOI
  31. Fitzgerald, 2015, Decision curve analysis, JAMA, 313, 409, 10.1001/jama.2015.37 · DOI · Paper page
  32. Van Calster, 2018, Reporting and interpreting decision curve analysis: a guide for investigators, Eur Urol, 74, 796, 10.1016/j.eururo.2018.08.038 · DOI · Paper page
  33. Balachandran, 2015, Nomograms in oncology: more than meets the eye, Lancet Oncol, 16, e173, 10.1016/S1470-2045(14)71116-7 · DOI · Paper page
  34. Katki, 2018, Implications of nine risk prediction models for selecting ever-smokers for computed tomography lung cancer screening, Ann Intern Med, 169, 10, 10.7326/M17-2701 · DOI · Paper page
  35. Ten Haaf, 2017, Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study, PLoS Med, 14, 10.1371/journal.pmed.1002277 · DOI · Paper page
  36. Faselis, 2022, Assessment of lung cancer risk among smokers for whom annual screening is not recommended, JAMA Oncol, 8, 1428, 10.1001/jamaoncol.2022.2952 · DOI
  37. Malhotra, 2016, Risk factors for lung cancer worldwide, Eur Respir J, 48, 889, 10.1183/13993003.00359-2016 · DOI · Paper page
  38. Chen, 2020, An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population, Chest, 157, 547, 10.1016/j.chest.2019.09.003 · DOI

Cited by

See all 43

Metadata

Authors
Pan, Z., Zhang, R., Shen, S., Lin, Y., Zhang, L., Wang, X., Ye, Q., Wang, X., Chen, J., Zhao, Y., Christiani, D. C., Li, Y., Chen, F., & Wei, Y.
Venue
eBioMedicine
Publisher
Elsevier BV
Published
2023-02
Volume
88
Pages
104443
ISSN
2352-3964
Cited by
43
References
9
Language
en
Licence
Funders
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • National Institutes of Health (CA092824, CA209414, CA249096, CA269398, ES000002)
  • National Natural Science Foundation of China (81973142, 82220108002, 82273737)
  • National Institute of Health
  • Nanjing Medical University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations. https://app.cochat.ai/papers/10.1016/j.ebiom.2023.104443
The paper
Pan, Z., Zhang, R., Shen, S., Lin, Y., Zhang, L., Wang, X., Ye, Q., Wang, X., Chen, J., Zhao, Y., Christiani, D. C., Li, Y., Chen, F., & Wei, Y. (2023). OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations. eBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104443

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.